-
Vector construction
Aperbio constructs vectors containing target genes through engineering methods such as gene cloning or gene editing. Aperbio provides nucleic acid extraction and electrophoresis solutions. It improves the user experience through special material processing to solve the atomization problem on the surface of the electrophoresis tank.
-
Virus purification and quantification
Aperbio's digital PCR and technical service platform provides a complete solution for viral host DNA residues. The accuracy of digital PCR can reliably detect the copy number of viral particles and infected cells. The digital PCR system is compliant with domestic and international regulatory requirements.
-
Pharmacokinetics and pharmacodynamics
Regulatory agencies conduct comprehensive preclinical and clinical safety evaluations for cell and gene therapy products, include biodistribution, vector shedding, gene expression, sequence integrity, and pharmacokinetic bioanalysis. Aperbio's qPCR system is adept at facilitating these assessments, and our robust technical service center is equipped to support users in developing and validating the necessary methodologies.
-
Quality and Safety
Regulatory agencies impose more rigorous safety standards for cell and gene therapy products. Aperbio's Pangaea qPCR system and Naica digital PCR system are capable of detecting stem cell residues, pathogenic microorganisms (e.g., mycoplasma), and verifying the origin of cells.
